摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(Z)-3-碘丙烯酸 | 6214-35-3

中文名称
(Z)-3-碘丙烯酸
中文别名
(Z)-(3)-碘丙烯酸
英文名称
(Z)-3-iodoprop-2-enoic acid
英文别名
(Z)-3-iodoacrylic acid;(Z)-3-iodo-2-propenoic acid;(Z)-3-iodopropenoic acid;cis-3-iodoacrylic acid
(Z)-3-碘丙烯酸化学式
CAS
6214-35-3
化学式
C3H3IO2
mdl
——
分子量
197.96
InChiKey
IBFDLVHJHUMSAC-UPHRSURJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    65 °C

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    6
  • 可旋转键数:
    1
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2916190090
  • 包装等级:
    III
  • 危险类别:
    8
  • 危险性防范说明:
    P260,P264,P280,P301+P330+P331,P303+P361+P353,P304+P340,P305+P351+P338,P310,P363,P405,P501
  • 危险品运输编号:
    3261
  • 危险性描述:
    H314
  • 储存条件:
    存储温度应保持在2-8°C,并需避免光照。

SDS

SDS:5a7b436dfd16a77c581c78f3caf92b49
查看
Name: cis-3-Iodoacrylic acid Material Safety Data Sheet
Synonym:
CAS: 6214-35-3
Section 1 - Chemical Product MSDS Name:cis-3-Iodoacrylic acid Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
6214-35-3 cis-3-Iodoacrylic acid unlisted
Hazard Symbols: C
Risk Phrases: 34

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.
Potential Health Effects
Eye:
Causes eye burns. Lachrymator (substance which increases the flow of tears).
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 6214-35-3: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 66 - 67 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C3H3IO2
Molecular Weight: 197.96

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong bases.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, hydrogen iodide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 6214-35-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
cis-3-Iodoacrylic acid - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.*
Hazard Class: 8
UN Number: 3261
Packing Group: II
IMO
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3261
Packing Group: II
RID/ADR
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3261
Packing group: II

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 6214-35-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 6214-35-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 6214-35-3 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (Z)-3-碘丙烯酸氢碘酸 作用下, 反应 24.0h, 以18%的产率得到3,3-diiodopropanoic acid
    参考文献:
    名称:
    受阻乙烯基硼酸酯酯的Heck-Mizoroki交叉偶联反应的机理研究是开发高立体选择性合成Viidenomycin的C1-C7 Z,Z,E-三烯合成基的关键方法
    摘要:
    乙烯基硼酸酯与电子上不同的(四取代)芳基碘化物的Heck-Mizoroki反应的机理研究表明,电子给体加速了交叉偶联,表明氧化加成步骤不是速率决定性的,并且有一定程度的发展。在速率确定步骤中的正电荷。这些结果被用作允许开发受阻乙烯基硼酸酯与电子缺陷型顺式-2-碘代丙烯酸甲酯的Heck-Mizoroki偶联反应条件的基础。通过一系列高度立体选择性的碘脱硼和Heck-Mizoroki反应,将生成的二烯基硼酸酯转变为三烯基碘化物前体,以进一步用于viridenomycin的总合成中。
    DOI:
    10.1021/jo0626010
  • 作为产物:
    描述:
    丙炔酸氢碘酸 作用下, 以 为溶剂, 以90%的产率得到(Z)-3-碘丙烯酸
    参考文献:
    名称:
    甲反-vinylogous酯阴离子等价物及其应用,以(+)的合成-布雷菲德菌素A
    摘要:
    已经开发了一种新的反式-乙烯基酯阴离子等价物,它可以与多种羰基体系反应。此外,利用乙烯基酰基阴离子当量的这种新变体的容易的酰化,已经完成了(+)-布雷菲德菌素A的简明全合成。
    DOI:
    10.1016/s0040-4039(00)02278-4
  • 作为试剂:
    描述:
    1α-ethynyl-1,2-dideoxy-3,5-di-O-(4-toluoyl)-D-ribofuranose四(三苯基膦)钯(Z)-3-碘丙烯酸三乙胺 作用下, 以 乙腈 为溶剂, 反应 48.0h, 以60%的产率得到1,4-bis[1,2-dideoxy-3,5-di-O-(4-toluoyl)-α-D-ribofuranosyl]butadiyne
    参考文献:
    名称:
    生物活性γ-亚烷基丁烯内酯库的扩展
    摘要:
    -具有脱氧核苷、类固醇和茂金属部分的亚烷基丁烯内酯是通过立体选择性顺序交叉偶联内酯化过程从相应的官能化末端炔烃与 3-碘丙烯酸合成的。丁烯内酯环形成的高选择性由 Pd/Cu 盐比保证。测试所得化合物的抗真菌和细胞抑制特性。最值得注意的是,带有脱氧核苷部分的γ-亚烷基丁烯内酯在微摩尔范围内显示出有希望的细胞抑制活性。
    DOI:
    10.1055/s-0028-1083181
点击查看最新优质反应信息

文献信息

  • An Efficient and Stereoselective Synthesis of Xerulin <i>via</i> Pd-Catalyzed Cross Coupling and Lactonization Featuring (<i>E</i>)-Iodobromoethylene as a Novel Two-Carbon Synthon
    作者:Ei-ichi Negishi、Asaf Alimardanov、Caiding Xu
    DOI:10.1021/ol990336h
    日期:2000.1.1
    [structure: see text] Xerulin, an inhibitor of cholesterol biosynthesis, has been synthesized from commercially available (E)-1-bromopropene, acetylene, and propynoic acid in five steps (longest linear sequence) in 30% overall yield and >96% stereoselectivity. The preparation of (E)-iodobromoethylene and its use in the Pd-catalyzed cross coupling are two of the novel aspects of the synthesis reported
    [结构:参见文本]胆固醇生物合成抑制剂Xerulin由市售(E)-1-溴丙烯,乙炔和丙酸经五个步骤(最长的线性序列)合成,总收率30%,> 96%立体选择性。(E)-碘溴乙烯的制备及其在Pd催化的交叉偶联中的用途是本文报道的合成的两个新颖方面。
  • Approaches to the Synthesis of (±)-Strychnine via the Cobalt-Mediated [2 + 2 + 2] Cycloaddition:  Rapid Assembly of a Classic Framework
    作者:Michael J. Eichberg、Rosa L. Dorta、Douglas B. Grotjahn、Kai Lamottke、Martin Schmidt、K. Peter C. Vollhardt
    DOI:10.1021/ja016333t
    日期:2001.9.1
    Five synthetic approaches to racemic strychnine (1), with the cobalt-mediated [2 + 2 + 2] cycloaddition of alkynes to indoles as the key step, are described. These include the generation and attempted cyclization of macrocycle 8 and the synthesis of dihydrocarbazoles 15, 22, and 26 and their elaboration to pentacyclic structures via a conjugate addition, dipolar cycloaddition, and propellane-to-spirofused
    描述了外消旋士的宁 (1) 的五种合成方法,其中钴介导的炔烃与吲哚的 [2 + 2 + 2] 环加成反应是关键步骤。这些包括大环 8 的生成和尝试环化以及二氢咔唑 15、22 和 26 的合成,以及它们分别通过共轭加成、偶极环加成和推进烷到螺旋融合骨架重排形成五环结构。最后讨论了1的成功全合成。烯炔基吲哚 40 与乙炔的环化和胺 49 的正式分子内 1,8-共轭加成形成五环 50,突出了短而高度收敛的路线(最长线性序列中的 14 个步骤)的发展。
  • When cobalt-mediated [2 + 2 + 2] cycloaddition reaction dares go astray: synthesis of unprecedented cobalt(<scp>iii</scp>)-complexes
    作者:Marion Delorme、Alexander Punter、Raquel Oliveira、Corinne Aubert、Yannick Carissan、Jean-Luc Parrain、Muriel Amatore、Paola Nava、Laurent Commeiras
    DOI:10.1039/c9dt03311d
    日期:——
    In sharp contrast with the standard [2 + 2 + 2] cycloaddition reaction of diyne/ene, cobalt-mediated cycloadditions with γ-alkylidenebutenolide led to unprecedented cobalt(III) polycyclic complexes. A plausible mechanism supported by a computational study based on an unusual fragmentation of the butenolide moiety was postulated to account for this original reaction.
    与二炔/烯的标准[2 + 2 + 2]环加成反应形成鲜明对比,钴介导的环加成与γ-亚烷基丁烯内酯形成了前所未有的钴(III)多环配合物。假定由基于丁烯内酯部分的不寻常断裂的计算研究支持的合理机制被认为是造成该原始反应的原因。
  • β-Acylvinyl intermolecular radical additions to double bonds: Stereoselective synthesis of functionalised (E)-α,β-unsaturated carboxylic acids
    作者:Francisco Foubelo、Francisco Lloret、Miguel Yus
    DOI:10.1016/s0040-4020(01)89700-3
    日期:——
    leads, after treatment with aqueous sodium fluoride, to the expected functionalized (E)-α,β-unsaturated carboxylic acids 3 in a stereoselective manner. The probable reaction mechanism involves free radical intermediates.
    在催化量的AIBN存在下,(Z)-3-碘丙烯酸(1)与亚化学计量的三丁基氯化锡(摩尔比为1:5)和过量的硼氢化钠(摩尔比为1:4)反应(摩尔比为1:0.18)和乙醇中过量的亲电子烯烃(2),在用氟化钠水溶液处理后,以立体选择的方式导致预期的官能化的(E)-α,β-不饱和羧酸3。可能的反应机理涉及自由基中间体。
  • Total Syntheses of (−)-Macrolactin A, (+)-Macrolactin E, and (−)-Macrolactinic Acid:  An Exercise in Stille Cross-Coupling Chemistry
    作者:Amos B. Smith、Gregory R. Ott
    DOI:10.1021/ja980203b
    日期:1998.4.1
    The total syntheses of the potent antiviral agent ()-macrolactin A (1) and two related family members, (+)-macrolactin E (5) and ()-macrolactinic acid (7), have been achieved, exploiting a unified, convergent, and highly stereocontrolled strategy. Extensive use of the palladium-catalyzed Stille cross-coupling reaction for the stereospecific construction of the three isolated dienes including macrocyclization
    强效抗病毒剂 (-)-macrolactin A (1) 和两个相关的家族成员 (+)-macrolactin E (5) 和 (-)-macrolactinic acid (7) 的全合成已经实现,利用统一的、收敛和高度立体控制的策略。广泛使用钯催化的 Stille 交叉偶联反应来构建三种分离的二烯(包括大环化),这是成功策略的基石。这些天然产物的全合成不再通过发酵获得,证实了它们的相对和绝对立体化学,并为进一步的生物学研究提供了可能的类似物。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物